Spirometry & Pulmonary Function Data
Buy and sell spirometry & pulmonary function data data. FEV1, FVC, flow-volume loops — pulmonary AI needs real breathing test data for COPD and asthma management.
No listings currently in the marketplace for Spirometry & Pulmonary Function Data.
Find Me This Data →Overview
What Is Spirometry & Pulmonary Function Data?
Spirometry and pulmonary function testing (PFT) measure how well lungs work by capturing metrics like forced expiratory volume in one second (FEV1), forced vital capacity (FVC), peak expiratory flow rate (PEFR), and flow-volume loops. These tests are essential for diagnosing and managing respiratory diseases, particularly COPD, asthma, and cystic fibrosis. As AI and machine learning tools increasingly power respiratory disease management and clinical trial platforms, demand for real, validated spirometry datasets has grown significantly. Data buyers include AI developers, medical device manufacturers, pharmaceutical companies running respiratory trials, and healthcare systems building predictive diagnostics.
Market Data
USD 993.8 million
Global Spirometer Market Size (2023)
Source: Global Market Insights
USD 1,157.9 million
Projected Market Size (2035)
Source: Future Market Insights
5.4%
Expected CAGR (2025–2035)
Source: Future Market Insights
50.46% of global market
North America Market Share (2025)
Source: Fortune Business Insights
Who Uses This Data
What AI models do with it.do with it.
AI-Driven Diagnostic Platforms
Companies developing algorithms that identify FEV1 and peak expiratory flow rate anomalies need validated spirometry datasets to train and validate respiratory AI models for early disease detection and clinical decision support.
Pharmaceutical & Clinical Trial Networks
Pharmaceutical companies and contract research organizations require authentic spirometry data for respiratory trials, including COPD and asthma studies, to support drug efficacy evaluation and regulatory submissions.
Digital Health & Remote Monitoring Platforms
Telehealth and home-based care providers use spirometry data to enable longitudinal tracking of patient respiratory metrics and integrate results into electronic health records for continuous disease management.
Medical Device Manufacturers
Spirometer and pulmonary function equipment makers use real-world data to validate device accuracy, calibrate algorithms, and demonstrate clinical performance to regulatory bodies.
What Can You Earn?
What it's worth.worth.
Individual Spirometry Records
Varies
Pricing depends on data completeness (FEV1, FVC, flow-volume loops), patient demographics, disease indication, and regulatory compliance (HIPAA de-identification status).
Longitudinal Patient Cohorts
Varies
Multi-year spirometry series with serial measurements command premium pricing; datasets supporting COPD or asthma cohorts are particularly valuable for AI training.
Clinical Trial-Grade Datasets
Varies
Fully annotated, quality-controlled spirometry datasets with matching clinical metadata (demographics, smoking history, comorbidities) attract highest buyer interest and pricing.
What Buyers Expect
What makes it valuable.valuable.
Accurate Spirometry Metrics
All key parameters must be present and calibrated: FEV1, FVC, FEV1/FVC ratio, peak expiratory flow rate, and flow-volume loops. Data should meet standardized pulmonary function testing protocols.
Clinical Context & Diagnosis
Records should include patient indication (COPD, asthma, cystic fibrosis, etc.), smoking history, and clinical outcome data. Longitudinal records with multiple test dates increase value significantly.
Data Completeness & Validation
Spirometry data must come from calibrated, FDA-cleared or CE-marked devices. Quality flags, technician notes, and acceptability criteria (ATS/ERS standards) should be documented.
De-Identification & Compliance
All personally identifiable information must be removed or pseudonymized per HIPAA and applicable data protection regulations. Provenance and consent documentation must be in order.
Companies Active Here
Who's buying.buying.
Develops advanced diagnostic spirometry devices and software; acquires real-world spirometry data to validate and train AI-driven interpretation algorithms.
Invests in connected and AI-enabled respiratory monitoring solutions; sources spirometry datasets to power telehealth and remote patient monitoring platforms.
Leading spirometer manufacturer; uses real spirometry data for device calibration, algorithm development, and clinical validation studies.
Develops connected spirometers with FDA clearance; sources spirometry datasets to improve AI over-reading accuracy and expand clinical trial data collection capabilities.
FAQ
Common questions.questions.
What types of spirometry data are most valuable?
Longitudinal datasets with multiple serial measurements over months or years, combined with detailed clinical metadata (diagnosis, smoking status, treatment history) and complete flow-volume loop data, command the highest prices. Datasets supporting COPD or asthma cohorts are especially sought after by AI developers and pharmaceutical companies.
How is the spirometry market growing, and why?
The global spirometer market is projected to grow at 5.4% CAGR through 2035, driven by rising respiratory disease prevalence (COPD, asthma), adoption of AI-driven diagnostics, and shift toward home-based and telehealth monitoring. Technological advances in portable, handheld, and connected devices are expanding test volume and data availability.
What regulatory and compliance requirements apply to spirometry data sales?
All spirometry data must be de-identified per HIPAA and comply with regional data protection laws (GDPR, etc.). Data should come from validated, FDA-cleared or CE-marked devices. Clinical trial datasets require additional quality controls and documentation of informed consent and data provenance.
Which regions and companies are driving demand for spirometry data?
North America dominates the market with 50.46% share, driven by high COPD and asthma prevalence and strong healthcare infrastructure. Key players include Vyaire Medical, Philips, Hill-Rom, and NuvoAir. Emerging markets are expanding spirometry screening programs, creating demand for reference datasets and algorithm training data in resource-constrained settings.
Sell yourspirometry & pulmonary functiondata.
If your company generates spirometry & pulmonary function data, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation